^
Association details:
Biomarker:IDH2 mutation + Chr del(1p) + Chr del(19q)
Cancer:Oligodendroglioma
Regimen:PCV (lomustine + Matulane (procarbazine hydrochloride) + vincristine)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
Excerpt:
ADULT GLIOMA: OLIGODENDROGLIOMA (IDH-MUTANT, 1p19q CODELETED)...Adjuvant Treatment WHO grade 2, KPS ≥60….Preferred Regimens...RT + adjuvant PCV (category 1)...Other Recommended Regimens...PCV